ChiCTR1800018506
结束
/
/
/
2018-09-21
/
/
危重病
Evaluation of BCL2 and TNFα as mRNA Biomarkers for Monitoring The Immune Response in Critically ill Children
Evaluation of BCL2 and TNFα as mRNA Biomarkers for Monitoring The Immune Response in Critically ill Children
Assess the mRNA of TNFα and BCL2 for prediction of HAI +/- MODS in our community.
单臂
其它
N/A
N/A
This study has not received any financial support or funding
/
50
/
2017-04-07
2017-11-11
/
1. aged 2-12 years; 2. admitted to PICU for 48 hours or more;
登录查看end-stage renal failure, end-stage liver failure, congenital immune deficiency;
登录查看no
/
IntraAb mRNA-LNP 实体肿瘤治疗
医麦客2025-06-20
科睿唯安 TS JCR
青塔2025-06-18
ADA 肥胖
Insight数据库2025-06-18
TGF-β 胰腺导管腺癌
中国医药生物技术协会2025-06-18
肿瘤治疗性疫苗
医麦创新药2025-06-18
β-地中海贫血 β-地
医麦创新药2025-06-18
D&D Pharmatech Inc. GC GLP-1/GCG
药时空2025-06-18
MTAP PRMT5 AI
晶泰科技2025-06-18